Influenza in the House: Diagnosis, Treatment, and Prophylaxis

Released On
September 30, 2021

Expires On
September 29, 2022

Media Type

Completion Time
45 minutes

Primary Care


Scroll to the Bottom of this Information to Begin this Course

This continuing education activity is provided by Vindico Medical Education.

This activity is supported in part by an educational grant from Genentech, a member of the Roche Group.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

Credit Available

  • Nurses — 0.75 Contact Hours
  • Nurse Practitioners — 0.75 Contact Hours (which includes 0.42 hour(s) of pharmacology)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

The intended audience for this activity is nurse practitioners and other health care professionals involved in the management of patients with influenza.

Program Overview

Although the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. With COVID-19 complicating influenza management, health care providers need better strategies for preventing, diagnosing, and treating influenza. Antivirals with different targets and mechanisms of action provide multiple therapeutic options and hold promise for improving treatment effectiveness. Influenza prophylaxis is also a very important component of management, yet providers are not adequately educated about it. In this continuing education activity, expert clinicians will discuss optimal ways to diagnose and manage influenza during the end stages of the COVID-19 pandemic.

Learning Objectives

Upon completion of this activity, participants should be better able to:
  • Differentially diagnose influenza early to optimize patient management and outcomes.
  • Select antiviral treatment for influenza based upon evidence of safety, efficacy, and ability to aid in postexposure prophylaxis


Activity Co-Chairs


Ruth Carrico, PhD, DNP, APRN, CIC, FSHEA, FNAP

University of Louisville School of Medicine
Division of Infectious Diseases
Louisville, KY


Neil S. Skolnik, MD, FAAFP

Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Associate Director
Family Medicine Residency Program
Abington – Jefferson Health
Abington, PA


Accreditation Statement

Vindico Medical Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

Vindico Medical Education will provide a maximum of 0.75 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

This activity is approved for 0.75 contact hour(s) of continuing education (which includes 0.42 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 21085116. This activity was planned in accordance with AANP Accreditation Standards and Policies.


Disclosures of Conflicts of Interest

In accordance with the American Nurses Credentialing Center’s Commission on Accreditation’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, faculty, and reviewers involved in the development of accredited content. Individuals have a relevant financial relationship if they have a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information is accurate at the time of content development.

Ruth Carrico, PhD, DNP, APRN, CIC, FSHEA, FNAP
  • Consulting Fee: AstraZeneca, Johnson & Johnson/Janssen, Pfizer, Sanofi Pasteur
  • Contracted Research: Sanofi Pasteur
Neil S. Skolnik, MD, FAAFP
  • Consulting Fee: AstraZeneca, Johnson & Johnson/Janssen, Pfizer, Sanofi Pasteur
  • Speakers Bureau: AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Lilly
  • Contracted Research: AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Sanofi

Reviewers report the following financial relationships

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Barbara A. Niedz, PhD, RN, CPHQ
  • Consulting Fee: Beckton Dickinson: Beckton Dickinson
  • Contracted Research: Beckton Dickinson

Chad Rittle, DNP, MPH, RN, FAAOHN
No relevant financial relationships to disclose.

Vindico Medical Education staff have no relevant financial relationships to disclose.

Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Instructions for Participation and Credit

To participate in this CE activity, you must read the objectives, answer the pretest questions, view the CE content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue a Contact Hour(s) Certificate.

Course Viewing Requirements

This site is best viewed with an HTML5 compatible browser. You can visit the independent (3rd party) site to determine if you have the latest version of your browser.

Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.

Disclosure of Unlabeled Use

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non—FDA-approved or investigational use of products/devices.


The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.

The opinions expressed in this educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Contact Information

For CME questions, please contact Vindico Medical Education at: